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Abstract: The U.S. Environmental Protection Agency’s (EPA) Water Laboratory Alliance relies on the
Centers for Disease Control and Prevention’s ultrafiltration-based Water Processing Procedure (WPP)
for concentration of biosafety level 3 (BSL-3) agents from 10 L to 100 L of drinking water. The WPP
requires comprehensive training and practice to maintain proficiency, resulting in a critical need
for quality control (QC) criteria. The aim of this study was to develop criteria using male-specific
(MS2) coliphage (BSL-2 agent) to minimize safety hazards associated with BSL-3 agents and to use
the criteria to evaluate analytical proficiency during a demonstration exercise. EPA Method 1602
with EasyPhage was used during the study to develop QC criteria for 100-mL, and 40–100 L samples.
The demonstration exercise indicated that the MS2 criteria would allow laboratories to demonstrate
proficiency using the WPP with 40–100 L samples. In addition, the QC criteria developed for 100-mL
samples has broad applicability at laboratories that are using MS2 for other types of analyses, such as
assessment of water treatment devices. The development of MS2 QC criteria allows laboratories to
develop and confirm ongoing proficiency using the WPP.
Keywords: male-specific (MS2); coliphage; drinking water; quality control criteria; ultrafiltration
1. Introduction
During emergency responses to drinking water contamination events, it may be necessary to
concentrate large volumes of water to detect biosafety level 3 (BSL-3) agents of concern, which can
be present at very low levels in drinking water. The U.S. Environmental Protection Agency’s (EPA)
Water Laboratory Alliance (WLA) currently relies on the Laboratory Response Network’s (LRN)
Water Processing Protocol (WPP), which is a tangential flow, hollow fiber ultrafiltration (UF)-based
procedure, for concentration and analysis of BSL-3 bioterrorism threat agents from large volumes (10-L
to 100-L) of drinking water. The LRN’s WPP requires comprehensive training and ongoing practice for
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laboratories to achieve and maintain proficiency. In addition, non-laboratory groups such as hazmat
(hazardous materials) responders may be required to collect and concentrate large-volume samples
in an effort to increase the number of samples that can be shipped and analyzed during drinking
water contamination incidents. As a result, it is critical that quality control (QC) criteria and method
performance information be available, especially for laboratories and responders who may use a
method for the first time during an emergency situation. Because BSL-3 agents are difficult to handle
and present significant safety hazards, the EPA collaborated with the Centers for Disease Control and
Prevention (CDC) from 2007 through 2009 to design and conduct a QC criteria development study
using a viral surrogate. During the QC criteria study design process, male-specific (MS2) coliphage
(American Type Culture Collection (ATCC®) 15597-B1™, family Leviviridae, genus Levivirus, strain
MS2 [1]) was evaluated as a potential non-BSL-3 virus [2,3] because it is readily available, has broad
applicability (i.e., is in widespread use), and has been successfully concentrated using UF.
MS2 is commonly used as an indicator of fecal contamination and is used to evaluate the efficacy
of size exclusion technologies for point-of-use and point-of-entry water treatment devices that are
manufactured and deployed worldwide. Its broad applicability, such as its use in evaluation of
the efficacy of systems to treat wastewater [4–12] and evaluation of ground-water sources [13] has
resulted in MS2 testing becoming an integral component of multiple standards, including the National
Sanitation Foundation’s (NSF) P248 protocol for testing Microbiological Water Purifiers for use in
Emergency Military Operations [14] and the EPA/NSF Environmental Technology Verification Program
(ETV) Protocol for equipment verification testing for inactivation of microbiological contaminants [15].
The World Health Organization (WHO) also recommends MS2 and somatic coliphage as surrogates
for pathogenic viruses in testing and evaluating household water treatment devices [16]. In addition,
multiple studies [17–20] have reported that MS2 can be successfully recovered from large-volume
water samples following concentration using UF.
During the preliminary phases of the QC criteria study, analyses were conducted to
evaluate MS2 spiking approaches, two analytical culture methods (Standard Methods (SM)
9224 F [21] and EPA Method 1602 [22]) and commercially-prepared plates with EasyPhage medium.
Commercially-prepared EasyPhage plates incorporate a bacterial stain that provides contrast between
blue plaques and a red bacterial host lawn, resulting in plaques that are much easier to identify
and enumerate than those on the media specified in EPA Method 1602. Based on the preliminary
results, a multi-laboratory study was conducted to generate QC criteria using Scientific Methods, Inc.
(SMI)-prepared spikes and EPA Method 1602 using EasyPhage medium.
Subsequent to the 2009 QC criteria development study, the EPA collaborated with the CDC
to conduct a demonstration exercise in 2012 that would increase the number of LRN laboratories
deemed proficient by the LRN to respond to a water contamination event using LRN’s WPP. MS2 was
included in the demonstration exercise as a viral surrogate due to the accessibility and practicality of
its associated analytical detection method (real-time reverse transcription polymerase chain reaction
(RT-PCR) by TaqMan® assay (Chapel Hill, NC, USA)).
This paper provides results from the QC criteria development study and limited results from
the demonstration exercise. It also provides an overview of MS2 QC criteria that laboratories could
use to achieve and maintain proficiency with the UF procedure without the potential safety hazards
and handling requirements associated with BSL-3 agents. In addition, the QC criteria provided for
small volume (100-mL) analyses using EPA Method 1602 with EasyPhage has broad international
applicability at laboratories that are using MS2 for other types of analyses, such as assessment of
water treatment devices, as use of EasyPhage medium will simplify media preparation and plaque
enumeration and allow for smaller laboratories with limited resources (e.g., water baths) to conduct
these types of analyses.
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2. Materials and Methods
A description of the materials and methods that were used during MS2 quantitative QC criteria
development are included in this section for: (a) the analytical method using small-volume (100-mL)
reference matrix and drinking water samples; and (b) large-volume (40–100 L) reference matrix and
drinking water samples concentrated using UF (Section 2.1); and the use of MS2 to demonstrate
proficiency as a BSL-3 viral surrogate during a demonstration exercise (Section 2.2).
2.1. MS2 QC Criteria Development
2.1.1. Ultrafiltration (UF)
The UF procedure utilized during the QC criteria development study used a hollow fiber ultrafilter
(Fresenius Optiflux® F200NR Dialysis Filter (Waltham, MA, USA)) to concentrate large volumes
(40–100 L) of water. Each water sample was treated with 0.5 mL/L of a 10% w/v solution of sodium
thiosulfate (if chlorine may have been present) and 10% sodium polyphosphate (NaPP) prior to
concentration. The filter was pre-treated with a fetal bovine calf serum solution that was removed
with a NaPP solution. The water sample was continually recirculated through the ultrafilter to remove
the water and leave particulates (>30,000 dalton molecular weight) in the concentrated retentate.
Analysts controlled the flow rate of the recirculation and removal of water by adjusting a flow regulator.
After concentrating the water sample, the filter was eluted with a wash buffer containing Tween® 80,
NaPP, and Antifoam Y-30. The concentrated volume and wash solution were combined to produce the
final retentate of ~300–500 mL.
2.1.2. Reference Matrix
Sterile phosphate-buffered saline (PBS) was selected as the reference matrix for which QC criteria
would be developed and serves as a standardized matrix that is repeatable during future analyses.
The QC criteria development study used 10X PBS (commercially available) that was diluted with
reagent-grade water to a final concentration of 0.01X (i.e., 40 mL (10X PBS)/40 L reagent-grade water).
2.1.3. Preliminary QC Criteria Analyses: Selection of Spiking Approach and Analytical Method
UF concentrates target and non-target analytes, as well as potential inhibitory substances present
in samples. As a result, the spiking approach and downstream analytical method had to be compatible
with UF and the resulting retentates. During preliminary phases of the QC criteria development
study, the spiking approach was confirmed and several analytical approaches were evaluated for both
small-volume and large-volume samples, the latter being concentrated using UF. Key preliminary QC
criteria study analyses are summarized in Table 1.
2.1.4. Spike Approach
Initial preliminary QC criteria study analyses were conducted using 100-mL PBS and 100-mL
drinking water (DW) samples spiked with BioBalls manufactured by BTF, a bioMérieux company
(ATCC® 15597-B1™). Unfortunately, BTF discontinued production of MS2 in BioBall® format due
to manufacturing issues and variability of the product, resulting in the need for an alternate
spike approach. Options considered included the use of either participant laboratory-prepared
or referee-prepared MS2 spiking suspensions. Use of referee-prepared spiking suspensions was
deemed more appropriate to minimize inter-laboratory variability, thus samples throughout the
remainder of the QC criteria study were spiked with SMI-propagated and titered MS2 (ATCC®
15597-B1™) suspensions.
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Table 1. Summary of key preliminary QC criteria analyses.
Phase n Volume Matrix Spike 1 Level per Sample (PFU) 2 Large Volume Processing Analytical Method
1A
3 100-mL PBS 100 PFU
NA SM 9224 F 3
3 100-mL DW 4 100 PFU
1B
3 40-L PBS 1000 PFU UF, followed by filtering and analyzing
100 mL of retentate per sample SM 9224 F
3
3 100-L DW 4 1000 PFU
2
3 100-mL PBS 100 PFU
NA Method 1602 5
3 100-mL DW 4 100 PFU
3 100-mL PBS 100 PFU
NA Method 1602
5,
using EasyPhage3 100-mL DW 4 100 PFU
3 40-L PBS 1000 PFU UF, followed by analyzing 100 mL of
retentate per sample Method 1602
5
3 100-L DW 4 1000 PFU
3 40-L PBS 1000 PFU UF, followed by analyzing 100 mL of
retentate per sample
Method 1602 5,
using EasyPhage3 100-L DW 4 1000 PFU
Notes: 1 Spiked with Scientific Methods, Inc. (SMI)-propagated and titered MS2 (ATCC® 15597-B1™)
suspensions; 2 Plaque forming unit (PFU); 3 Samples were processed according to Standard Methods 9224
F: Detection of Coliphages-Membrane Filter Method (SM 9224 F); 4 Drinking water (DW); 5 Samples were
processed according to the Single Agar Layer (SAL) procedure in EPA Method 1602, Section 12.
2.1.5. Analytical Methods
Analytical methods were assessed in two phases and included the evaluation of membrane
filtration (Phases 1A and 1B), and single agar layer (SAL) methods and media (Phase 2). During Phase
1A, 100-mL PBS and 100-mL DW samples were each spiked with 1 mL of ~100 plaque forming units
(PFU)¨mL´1 MS2 spiking suspension prepared by SMI. Following spiking, these 100-mL samples were
analyzed according to Standard Methods 9224 F: Detection of Coliphages-Membrane Filter Method
(SM 9224 F). Phase 1A results indicated that SMI-prepared spikes and SM 9224 F were appropriate
for evaluation with large-volume samples. During Phase 1B 40-L PBS and 100-L DW samples were
analyzed, with 40-L of PBS (rather than 100-L) being utilized as a time- and cost-saving measure.
Each large-volume sample was spiked with 1 mL of ~1000 PFU¨mL´1 MS2 spiking suspension
prepared by SMI and concentrated using UF. Following concentration, 100 mL of the retentate from
each sample was filtered and analyzed using SM 9224 F. While Phase 1A results indicated that SM
9224 F performed well for analyses of 100-mL samples, low recoveries (<5%) observed for large-volume
(40-L PBS and 100-L DW) samples during Phase 1B indicated that SM 9224 F, as written, was not
acceptable for the study. To address the low recoveries observed for the large-volume samples,
retentates with final MgCl2 concentrations of 0.1 M, 0.25 M, and 0.5 M were evaluated to potentially
increase adherence of MS2 to the membrane filter. However, this approach did not mitigate the low
recovery issue for large-volume samples. Based on these results, an alternate method was evaluated
during Phase 2 preliminary analyses.
During Phase 2, small-volume samples and retentate from concentrated large-volume samples
were processed according to the SAL procedure in EPA Method 1602: Male-specific (F+) and Somatic
Coliphage in Water by Single Agar Layer (SAL) Procedure (EPA Method 1602, Section 12.0). However,
because there was considerable concern regarding the time-consuming nature of the method and water
bath requirements for tempering the molten agar for analyses, half of the samples were processed
using commercially-prepared plates with EasyPhage medium by SAL as per Method 1602 to determine
whether it could be used for QC criteria development. The potential advantages of EasyPhage
medium included eliminating the need to prepare and temper large volumes of media in a water
bath, as well as having plaques that were easier to identify and count due to the incorporation of a
bacterial stain that provides contrast between blue plaques and the red bacterial host lawn. Prior to
concentration and/or analysis during Phase 2, each 100-mL PBS and 100-mL DW sample was spiked
with 1 mL of ~100 PFU¨mL´1 MS2 spiking suspension and each large-volume sample (40-L PBS and
100-L DW) was spiked with 1 mL of ~1000 PFU¨mL´1 MS2 spiking suspension prepared by SMI.
Recoveries were improved for large-volume sample retentates analyzed using Method 1602, compared
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to SM 9224 F, regardless of media. Since higher recoveries were observed when EasyPhage was used,
compared to EPA Method 1602 as written, EasyPhage medium was used for all subsequent QC criteria
development analyses.
2.1.6. QC Criteria Development for the Analytical Method (without UF) and the UF Procedure
Recovery and precision QC criteria were developed for both the analytical method and the UF
procedure. To develop the analytical method QC criteria, small-volume (100-mL) PBS and DW samples
were processed using EPA Method 1602 with EasyPhage medium (without UF). These criteria will
enable laboratories to confirm that analytical method performance is acceptable, independent of UF.
To develop QC criteria for the UF procedure, large-volume (40-L PBS or 100-L DW) samples were
concentrated using UF and MS2 detected using EPA Method 1602 with EasyPhage medium.
2.1.7. Laboratory Selection and Analyses
Twelve environmental/public health volunteer laboratories were recruited to participate in the
study, six of which were members of the EPA WLA. Prior to generating data for development of
QC criteria, the 12 participant laboratories were required to develop and demonstrate proficiency
with UF and to practice the use of EPA Method 1602 with EasyPhage medium. To demonstrate
proficiency with UF, laboratories spiked 40-L PBS and 100-L DW samples with Enterococcus faecalis
550 colony forming unit (CFU) BioBalls (ATCC® 29212™) according to EPA Method 1600: Enterococci
in Water by Membrane Filtration Using membrane-Enterococcus Indoxyl-β-D-Glucoside Agar (mEI) [23].
Laboratories were required to achieve E. faecalis recoveries of ě50% to be considered proficient using
UF. To practice using EPA Method 1602 and EasyPhage medium, laboratories analyzed unspiked
and spiked 100-mL PBS and 100-mL DW samples. Laboratories were required to meet EPA Method
1602 QC criteria using EasyPhage media to be considered proficient. Once laboratories demonstrated
proficiency with both UF and EPA Method 1602, study analyses were conducted.
For development of analytical method criteria, independent of UF, small-volume samples were
analyzed (four, 100-mL PBS samples and four, 100-mL DW samples). Each sample was spiked with
1 mL of ~100 PFU¨mL´1 MS2 spiking suspension prepared by SMI and processed according to EPA
Method 1602 using EasyPhage medium. Results from analyses of spiked, 100-mL PBS samples were
used to generate initial precision and recovery (IPR) and ongoing precision and recovery (OPR) criteria
for EPA Method 1602 with EasyPhage medium. Results from analyses of spiked, 100-mL DW samples
were used to generate matrix spike (MS) and matrix spike/matrix spike duplicate (MS/MSD) criteria
for EPA Method 1602 with EasyPhage medium.
For development of QC criteria for UF, large-volume samples (four, 40-L PBS samples and
four, 100-L DW samples) were each spiked with 1 mL of SMI-prepared MS2 spiking suspension at
~1000 PFU¨mL´1 and concentrated using UF. Retentate was processed according to EPA Method
1602 using EasyPhage medium. Results from these analyses were used to generate IPR, OPR, MS, and
MS/MSD criteria for large-volume samples concentrated by UF.
2.1.8. Calculations and Statistical Analyses
Two separate outlier tests, the Youden test for outlying laboratories and the Grubbs test for
outlying results, were applied to the data used to determine QC criteria to assess whether the data
were representative of the population of laboratories proficient in performing the method. Details on
the application of these outlier tests are found in the American Society for Testing and Materials (ASTM)
guidance D2777-98 [24]. Data identified as outliers were excluded from QC criteria calculations but
not method performance summaries.
QC recovery and precision criteria were developed based on prediction intervals from all valid,
spiked PBS reference matrix results for initial and ongoing performance, and all valid spiked drinking
water sample results for MS and MS/MSD. When determining method performance, IPR criteria
were applied to the analytical results of four replicate PBS samples; OPR criteria were applied to
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the analytical results of a single PBS sample. Recovery prediction limits were calculated based on
within- and between-laboratory variance components [25]. When determining method performance
in drinking water, recovery criteria were applied to the analytical results of a single MS sample.
These variance components were calculated with PROC MIXED from SAS version 9 [26] by applying
the maximum likelihood method of estimation to the recovery results. IPR criteria were calculated
using an upper prediction limit for the relative standard deviation (RSD) of four replicate sample
results (PBS) and MS/MSD precision criteria were calculated using an upper prediction limit for the
relative percent difference (RPD) of two replicate sample results (drinking water). The exact formulas
used to calculate the recovery and precision criteria were dependent on the distribution of the study
sample results. All outlier tests were performed and all QC specifications were determined using
untransformed results, because the distribution of individual recoveries did not depart from a normal
distribution based on graphical and statistical assessments.
2.2. Demonstration Exercise
2.2.1. Laboratory Selection
Thirteen public health/environmental laboratories were identified based on previous participation
in the QC criteria study or experience with LRN’s WPP to participate as volunteers in a demonstration
exercise to evaluate laboratory proficiency with the LRN WPP, with nine of those laboratories being
members of the EPA WLA.
2.2.2. Analyses
MS2 was used as a viral surrogate for laboratories to demonstrate the ability to correctly perform
secondary concentration for viruses. MS2 (ATCC® 15597-B1™) stocks were produced at CDC using
trypticase soy broth, streptomycin/ampicillin, and host bacteria E. coli Famp (ATCC® 700891™)
according to ATCC guidance. Frozen, enumerated stocks used for spiking suspensions were diluted
to a concentration of 100,000 PFU¨mL´1 by preparing 10-fold dilutions in PBS diluent consisting of
0.01 M PBS (Dulbecco’s Modification, pH 7.4), 0.01% (w/v) Tween® 80, and 0.001% (w/v) Antifoam
Y-30 emulsion. MS2 spiking suspensions were enumerated by SAL per EPA Method 1602, as written
(without EasyPhage). MS2 RNA was extracted from water concentrates using a Qiagen Viral RNA
Mini Kit, and RT-PCR analyses of MS2 spiking suspensions and water samples were performed using
a TaqMan® assay [18].
Prior to analyzing samples from the demonstration exercise, the participant laboratories had to
analyze samples using the RT-PCR protocol to demonstrate the ability to successfully detect MS2.
Each laboratory performed ribonucleic acid (RNA) extraction and limit of detection (LOD) with RT-PCR
analyses using the MS2 positive control stock (100,000 PFU¨mL´1) provided by CDC. Following RNA
extraction, 10-fold dilutions (1:10, 1:100, 1:1000) of the extracted RNA were made and assayed by
RT-PCR. Laboratories were expected to achieve cycle threshold (Ct) values for the undiluted stock
ranging from 23 to 27, along with producing a trend of increasing Ct values (roughly three Ct values
for each 10-fold dilution) for the dilutions.
As part of the larger demonstration exercise, each participant laboratory received two blinded
tubes that contained either 1 mL of MS2 spiking suspension (100,000 PFU¨mL´1) or 1 mL of deionized
water (DI water). Each laboratory spiked 40-L samples (laboratory tap water) with the blinded tubes
(one sample per tube) and concentrated using UF. A secondary concentration step was performed on a
portion of the retentate using Centricon® Plus-70 microconcentrators before being analyzed by RT-PCR.
Since the demonstration exercise included other non-viral analytes, the secondary concentration step
was performed only on a portion of the concentrated sample to allow for detection of the other analytes
using the remainder of the concentrated sample. Based on testing at CDC, it was expected that 1:4 and
1:10 sample dilutions from spiked samples would result in average Ct values of 32–36 for a 1:4 dilution
Water 2016, 8, 248 7 of 14
and 35–40 for a 1:10 dilution. These values could vary based on the quality of tap water tested by each
laboratory and could also be lower, as assay performance improves with experience.
3. Results
3.1. MS2 QC Criteria Development
For the QC criteria development study, data review forms were used to ensure that the data
packages submitted by each participant laboratory were complete and that study-specific and
method-specific requirements were met. Data provided for each sample was reviewed to confirm that
original forms were submitted, QC checks were performed and exhibited the appropriate response,
method-specific holding times were met, media and reagents were used within expiration dates, and
samples were spiked appropriately. Only valid results were included, as described below.
3.1.1. Results of Preliminary QC Criteria Analyses: Selection of Spiking Approach and
Analytical Method
Mean recoveries for 100-mL PBS and DW samples spiked with SMI-prepared MS2 spikes and
analyzed using SM 9224 F (Phase 1A) were 110% and 109%, respectively. Recovery results of
large-volume water samples (40-L PBS or 100-L DW) spiked with SMI-prepared spikes and analyzed
using SM 9224 F (Phase 1B) were <5%. Evaluation of three final concentrations of 0.1 M, 0.25 M, and
0.5 M MgCl2 in the retentates (large volume samples concentrated using UF) analyzed using SM 9224 F
resulted in similar recoveries (<5%). To address the poor recoveries, analyses were conducted using
EPA Method 1602 (Phase 2). Mean recoveries from 40-L PBS and 100-L DW samples improved to 26%
and 29% for EPA Method 1602 as written, respectively. EPA Method 1602 with EasyPhage medium
provided mean MS2 recoveries for 40-L PBS and 100-L DW samples of 38% and 48%, respectively
(Phase 2).
3.1.2. Results of QC Criteria Development for the Analytical Method (without UF) and the
UF Procedure
Laboratory-specific 100-mL PBS and 40-L PBS sample results are provided in Table 2;
laboratory-specific 100-mL and 100-L DW results are provided in Table 3. While the overall mean
recoveries for the 100-mL PBS and 100-mL DW samples were only 64.7% and 67.4%, respectively;
it should be noted that four laboratories (4, 6, 9, and 12) achieved higher MS2 recoveries from 100-mL
PBS (78.3%, 96.3%, 96.1%, 102%, respectively) and 100-mL DW (77.3%, 95.2%, 134%, 106%, respectively)
samples compared to the other laboratories.
QC acceptance criteria for recovery and precision were developed for EPA Method 1602 (analytical
method) with EasyPhage media and MS2 ATCC® 15597-B1™ (SMI-prepared spikes), using all valid,
spiked 100-mL sample results. QC acceptance criteria for recovery and precision using the LRN
UF procedure were developed using all valid, spiked 40-L PBS and 100-L DW sample results.
The calculated IPR (four, 100-mL spiked PBS samples or four, 40-L spiked PBS samples), OPR (one,
100-mL spiked PBS sample or one, 40-L spiked PBS sample), MS (one, 100-mL spiked DW sample or
one, 100-L spiked DW sample), and MS/MSD (two, 100-mL spiked DW samples or two, 100-L spiked
DW samples) QC acceptance criteria are provided in Table 4.
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Table 2. Summary of MS2 recoveries for spiked, 100-mL and 40-L PBS samples analyzed using EPA
Method 1602 and EasyPhage 1.
Lab
100-mL PBS Samples (n = 4) 40-L PBS Samples (n = 4) 2
Mean
Recovery (%) SD





3 (%) RSD 4 (%)
Range of
Recoveries (%)
1 47.1 9.19 19.5 35.6–56.2 36.9 7.47 20.3 27.4–44.5
2 49.1 2.78 5.66 45.3–52.0 53.1 8.92 16.8 43.1–64.4
3 5 59.5 15.0 25.2 47.2–80.3 - - - -
4 78.3 2.97 3.79 74.4–81.0 37.4 6.79 18.2 31.2–46.5
5 45.4 3.99 8.78 39.7–48.8 37.9 3.09 8.14 35.5–42.5
6 96.3 7.09 7.37 87.6–102 38.7 5.66 14.6 32.2–45.1
7 6 44.1 11.5 26.0 34.7–60.3 55.5 3.51 6.33 53.1–58.0
8 54.8 5.92 10.8 48.4–60.3 37.2 2.42 6.50 35.5–38.9
9 96.1 18.3 19.0 84.3–123 28.5 10.5 36.7 22.7–44.1
10 7 - - - - - - - -
11 51.5 4.12 8.00 48.2–56.7 43.0 6.33 14.7 35.2–50.5
12 102 8.15 8.02 92.5–111 48.3 5.13 10.6 41.4–53.6
13 52.5 7.28 13.9 46.3–62.8 26.2 8.51 32.5 17.9–34.9
Overall 64.7 9.25 8 14.9 9 34.7–123 40.0 6.97 8 19.9 9 17.9–64.4
Notes: 1 All of the laboratories had UF experience, only two laboratories (3 and 7) had previous experience
using EPA Method 1602, and none had experience with EasyPhage; 2 Mean recovery includes two PBS samples
(n = 2) for Laboratory 8 and three PBS samples (n = 3) for Laboratory 13; 3 Standard deviation; 4 Relative
standard deviation; 5 Lab 3 utilized a laboratory-specific UF protocol; therefore, PBS data was invalidated; 6 Lab
7 only processed two 40-L samples; 7 Laboratory 10 did not analyze samples due to time constraints; 8 Pooled
within-laboratory SD was determined by calculating the square root of the mean of the laboratory variances;
9 Pooled within-laboratory RSD was determined by calculating the square root of the mean of the squared
laboratory RSDs.
Table 3. Summary of MS2 recoveries for spiked, 100-mL and 100-L DW samples analyzed using EPA
Method 1602 and EasyPhage 1.
Lab
100-mL DW Samples (n = 4) 100-L DW Samples (n = 4)
Mean
Recovery (%) SD





2 (%) RSD 3 (%)
Range of
Recoveries (%)
1 45.4 4.87 10.7 41.2–52.5 9.52 3.69 38.8 6.63–14.9
2 27.6 4.32 15.6 21.7–32.1 5.64 2.68 47.5 2.42–8.90
3 58.3 12.2 20.9 47.2–74.6 45.3 6.09 13.4 39.9–54.0
4 77.3 12.4 16.0 71.1–95.9 33.1 13.9 41.9 16.3–46.4
5 50.4 6.00 11.9 43.0–57.0 32.0 10.7 33.3 21.0–44.4
6 95.2 10.8 11.3 85.9–110 49.8 6.83 13.7 46.2–60.0
7 4 58.2 8.48 14.6 51.1–70.3 41.2 3.66 8.89 38.6–43.8
8 55.3 11.5 20.8 39.3–66.7 41.5 7.62 18.4 34.6–51.5
9 5 134 6.80 5.09 125–140 31.9 10.1 31.8 24.7–39.0
10 6 - - - - - - - -
11 54.5 3.73 6.84 49.1–57.6 38.2 3.92 10.3 33.0–41.4
12 106 7.28 6.86 100–116 17.1 19.5 114 0.00–34.8
13 46.5 3.66 7.87 43.0–50.4 28.0 15.5 55.5 16.6–49.8
Overall 67.4 8.31 7 13.4 8 21.7–140 30.6 10.4 7 47.3 8 0.00–60.0
Notes: 1 All of the laboratories had UF experience, only two laboratories (3 and 7) had previous experience
using EPA Method 1602, and none had experience with EasyPhage; 2 Standard deviation; 3 Relative standard
deviation; 4 Lab 7 only processed two 100-L DW samples; 5 Mean recovery includes two DW samples
(n = 2) for Laboratory 9; 6 Laboratory 10 did not analyze samples due to time constraints; 7 Pooled
within-laboratory SD was determined by calculating the square root of the mean of the laboratory variances;
8 Pooled within-laboratory RSD was determined by calculating the square root of the mean of the squared
laboratory RSDs.
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Table 4. Calculated IPR, OPR, MS and MS/MSD criteria for analytical method (100-mL samples) and
LRN UF procedure (40-L PBS and 100-L DW samples) based on 95% prediction interval.
Performance Test
Analytical Method LRN UF Procedure
Acceptance Criteria Acceptance Criteria
PBS Samples 100-mL PBS Samples 40-L PBS Samples
IPR (4 PBS samples) Mean Percent Recovery 18%–105% 21%–100%
IPR (4 PBS Samples) Precision 1 26% 32%
OPR 2 (1 PBS sample) 16%–107% 18%–100%
DW Samples 100-mL DW Samples 100-L DW Samples
MS 3 (1 DW sample) Mean Percent Recovery 16%–114% 2%–100%
MS/MSD 4 (2 DW samples) Precision 39% 95%
Notes: 1 Precision as maximum RSD; 2 Ongoing precision and recovery (OPR) as percent recovery; 3 If an
MS/MSD pair is run, each individual recovery, rather than the mean of the two recoveries, is compared to the
percent recovery criterion; 4 Precision as maximum RPD of MS/MSD pair.
3.2. Demonstration Exercise MS2 Analyses
Summary Ct values generated during the LOD study prior to analyses of samples from the
demonstration exercise are provided in Table 5. Results are based on data from 11 of the 13 laboratories.
The remaining two laboratories were not able to conduct LOD analyses due to time constraints.
The LOD analyses indicated that the participating laboratories achieved acceptable results for the
RT-PCR procedure.
Table 5. Summary limit of detection (LOD) results.





Summary results from the demonstration exercise for the 13 laboratories are provided in Table 6.
Each of the 13 laboratories successfully recovered MS2 from their spiked 40-L DW sample and detected
MS2 RNA in replicate RT-PCR assays. Of particular note, 11 laboratories were able to detect MS2 in
the undiluted sample and the 1:10 dilution, and all were able to detect MS2 in the 1:4 dilution.
Table 6. Summary of demonstration exercise results.





4.1. Preliminary QC Criteria Analyses: Selection of Spiking Approach and Analytical Method
The preliminary QC criteria study analyses described in Section 2.1.3 were conducted to
confirm the spiking approach, and select an analytical method and media for detection of MS2
from small-volume (100-mL PBS and 100-mL DW) samples and large-volume (40-L PBS and 100-L
DW) samples concentrated by UF. A number of options were considered for spiking (e.g., BioBalls
and SMI-propagated spikes) and analytical methodology (e.g., SM 9224 F, EPA Method 1602 with
EasyPhage medium). Based on results from the preliminary analyses presented in Section 3.1.1,
subsequent QC criteria development analyses used MS2 spiking suspensions procured from SMI
and EPA Method 1602 with EasyPhage medium. In addition to having better recoveries for large
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volume samples in comparison to SM 9224 F, EPA Method 1602 with EasyPhage medium has several
advantages, including a significant reduction in media preparation, elimination of need to temper
media in a water bath, and the incorporation of a bacterial stain that provides contrast between the blue
MS2 plaques and red bacterial host lawn. It should be noted that subsequent to this study, EasyPhage
medium was approved through the EPA Alternate Test Procedure (ATP) program for analysis of
drinking water samples under the EPA Groundwater Rule.
4.2. QC Criteria Development Analyses for the Analytical Method (without UF) and the UF Procedure
4.2.1. Matrix Effects with UF
In contrast to 100-mL samples processed by the analytical method without UF, there are indications
of matrix interferences for samples concentrated using UF. For example, results for 100-L DW samples
exhibited increased variability in comparison to 40-L PBS samples, though this increase may simply be
related to the larger sample volume for drinking water. Also, laboratories 1 and 2 reported mean MS2
recoveries of 9.52% and 5.64% from 100-L DW samples, but reported much higher recoveries (36.9%
and 53.1%, respectively) from 40-L PBS samples. The lower recoveries and increased variability in
100-L DW samples compared to 40-L PBS may be due to a matrix effect and/or inhibitors concentrated
in some retentates.
4.2.2. Laboratory Proficiency
While all of the laboratories had experience with UF, with the exception of laboratories 3 and
7 all others were using EPA Method 1602 for the first time, and none had experience with EasyPhage
medium. Although each participating laboratory conducted analyses to become familiar with the
UF procedure and EPA Method 1602 using EasyPhage medium prior to analyzing samples to collect
data for development of QC criteria, observations indicate that some laboratories may not have been
proficient with MS2 analyses.
During analysis of large-volume samples for development of UF QC criteria, laboratories also
processed 100-mL PBS samples (OPRs) as QC checks to confirm that they were in control using EPA
Method 1602 and EasyPhage medium. When comparing 100-mL PBS sample results generated during
these analyses to results generated earlier (for development of analytical method criteria, independent
of UF), results for some laboratories improved, an indication that laboratory proficiency was still being
enhanced. This observation suggests the need to ensure that analytical method proficiency with EPA
Method 1602 and EasyPhage is established prior to implementing MS2 for use as a QC check with the
LRN UF procedure.
In addition, four laboratories (4, 6, 9, and 12) achieved higher MS2 recoveries (means ranging
from 78.3% to 134%) from 100-mL PBS and 100-mL DW samples compared to the other laboratories.
Of particular concern were those laboratories with sample recoveries in excess of 100%. It was
suspected that MS2 recoveries may have been affected by seemingly minor nuances in procedural
application that could have artificially increased recoveries. As a result, laboratories were asked
whether each sample was individually spiked and combined with the bacterial host/medium mixture
(individual processing) or if all the samples were prepared at the same time (batched processing).
Batched processing would result in longer contact time between the host cells and MS2 prior to plating,
which could lead to unexpectedly high recoveries (i.e., MS2 could have replicated prior to media
solidification). Laboratories were also asked whether MS2 spike vials were vortexed before spiking, and
the length of time between vortexing and spiking. Failure to vortex MS2 spikes according to the study
instructions, or an increased length of time between vortexing and spiking, may have contributed to
coliphage aggregates forming, or not being properly dispersed, resulting in higher or lower recoveries.
While no processing differences were identified through discussions with the participating laboratories,
it is possible that some differences in recoveries can be attributed to differences in how laboratories
conducted analyses.
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4.2.3. Warning Tool Criteria
QC criteria developed for implementation of the EPA microbiological methods are based on
95% prediction intervals (See Table 4). However, because not all the laboratories were familiar with
EPA Method 1602 prior to this study and given the results discussed above, it is understood that
they may not have been proficient despite practicing prior to conducting QC criteria development
study analyses. As a result, the QC criteria that were developed using the 95% prediction interval
may not be appropriately stringent. To ensure that laboratories have useful criteria for future
implementation purposes, an additional set of QC criteria were developed based on 90% prediction
intervals. These additional criteria are provided as a “warning tool”. While not required, it is
recommended that laboratories meet the warning tool criteria (90% prediction interval), rather than
the QC criteria (95% prediction interval), as failure to do so may indicate lack of proficiency.
The warning tool criteria for recovery and precision were developed for EPA Method 1602
(analytical method) with EasyPhage media and MS2 ATCC® 15597-B1™ (SMI-prepared spikes), using
all valid, spiked 100-mL results. Warning tool criteria for recovery and precision using the LRN UF
procedure were developed using all valid, spiked 40-L PBS and 100-L DW results. The calculated IPR
(four, 100-mL spiked PBS samples or four 40-L spiked PBS samples), OPR (one, 100-mL spiked PBS
sample or one, 40-L spiked PBS sample), MS (one, 100-mL spiked DW sample or one, 100-L spiked DW
sample), and MS/MSD (two, 100-mL spiked DW samples or two, 100-L spiked DW samples) warning
tool criteria are provided in Table 7.
Table 7. Warning tool–IPR, OPR, MS and MS/MSD criteria for analytical method (100-mL samples)
and LRN UF procedure (40-L PBS and 100-L DW samples) based on 90% prediction interval.
Performance Test
Analytical Method LRN UF Procedure
Acceptance Criteria Acceptance Criteria
PBS Samples 100-mL PBS Samples 40-L PBS Samples
IPR (4 PBS samples) Mean Percent Recovery 26%–100% 25%–100%
IPR (4 PBS samples) Precision 1 23% 28%
OPR 2 (1 PBS sample) 24%–100% 21%–100%
DW Samples 100-mL DW Samples 100-L DW Samples
MS 3 (1 DW sample) Mean Percent Recovery 25%–105% 7%–100%
MS/MSD 4 (2 DW samples) Precision 33% 79%
Notes: 1 Precision as maximum RSD; 2 Ongoing precision and recovery (OPR) as percent recovery; 3 If an
MS/MSD pair is run, each individual recovery, rather than the mean of the two recoveries, is compared to the
percent recovery criterion; 4 Precision as maximum RPD of MS/MSD pair.
4.2.4. Criteria Implementation
It should be noted that spiked, 100-mL PBS samples and spiked, 100-mL DW QC samples
should always be processed along with large-volume samples concentrated by UF. In the event that a
laboratory fails UF QC criteria, the data from the small volume analyses (without UF) can be used
to determine whether the problem is associated with the UF concentration procedure or the MS2
analytical method. Implementation of these criteria, especially the warning tool, will allow laboratories
to demonstrate proficiency for large-volume sample concentration using MS2. In addition, the criteria
for EPA Method 1602 with EasyPhage could also have broad applicability at laboratories that are using
MS2 for other types of analyses, such as assessment of water treatment devices, if these laboratories
wish to implement use of EasyPhage media.
4.3. Demonstration Exercise
Of the 13 participant laboratories, all successfully recovered and detected MS2 using the LRN
WPP followed by RT-PCR. Two laboratories were unable to detect MS2 from undiluted extracts due to
inhibition from constituents in the concentrated water samples, but were able to successfully obtain Ct
values from the 1:4 and/or 1:10 sample dilutions. These results illustrate the utility of testing dilutions
Water 2016, 8, 248 12 of 14
to detect analytes in the presence of PCR inhibitors, especially when targeting RNA using RT-PCR.
These data demonstrated successful use of MS2 to confirm proficiency with the LRN WPP procedure,
which included concentration with UF and Centricon® followed by detection using RT-PCR.
For molecular detection of MS2 in water, the theoretical method LOD from this study was
ď100,000 PFU in a 40-L sample. Hill et al. [27] reported a similar RT-PCR method LOD of 20,000 to
500,000 virions for noroviruses recovered from 50-L groundwater samples, using a UF-based procedure
similar to LRN’s WPP.
5. Conclusions
Increased laboratory proficiency using the LRN UF protocol will enhance the WLA’s ability to
respond to drinking water contamination events. The results of the QC criteria development study and
demonstration exercise indicate that MS2 can be used to develop and maintain laboratory proficiency
for the UF procedure and the overall LRN WPP for concentration of large-volume water samples.
Although the demonstration exercise used an RT-PCR assay for detection of MS2, it is recommended
that laboratories use EPA Method 1602 with EasyPhage to demonstrate proficiency with UF, as QC
criteria would need to be developed for UF followed by RT-PCR to ensure the criteria are accurate
measures of performance. Availability of QC criteria using MS2 allows laboratory analysts to assess
proficiency with UF procedures without requiring BSL-3 agents and facilities. In addition, the QC
criteria provided for small volume (100-mL) analyses using EPA Method 1602 with EasyPhage has
broad applicability across a range of laboratories that are using MS2 for other types of analyses
worldwide, such as assessment of water treatment devices, as use of EasyPhage medium will simplify
media preparation and plaque enumeration, and allow for smaller laboratories with limited resources
to conduct MS2 analyses.
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LRN Laboratory Response Network
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UF Ultrafiltration
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